A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.

about

A dynamic N-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

P2860

Q57293800-CFDC4B91-F4D4-40BD-B2F1-2B79EA585574

P2860

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.

Item

http://www.wikidata.org/entity/Q40059049

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A regulatory circuit composed ...... ng cancer cell aggressiveness.

@en

type

Item

label

A regulatory circuit composed ...... ng cancer cell aggressiveness.

@en

prefLabel

A regulatory circuit composed ...... ng cancer cell aggressiveness.

@en

P1476

A regulatory circuit composed ...... ung cancer cell aggressiveness

@en

P2093

B Deng

http://www.w3.org/2001/XMLSchema#string

F Yan

http://www.w3.org/2001/XMLSchema#string

J Pang

http://www.w3.org/2001/XMLSchema#string

J R Molina

http://www.w3.org/2001/XMLSchema#string

N Shen

http://www.w3.org/2001/XMLSchema#string

N Zhao

http://www.w3.org/2001/XMLSchema#string

P Yang

http://www.w3.org/2001/XMLSchema#string

S Liu

http://www.w3.org/2001/XMLSchema#string

Y Yang

http://www.w3.org/2001/XMLSchema#string

P2860

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells

Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.

Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell

Cancer statistics, 2007

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.

Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.

Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.

P2888

onc.2017.305

P304

6919-6928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2017.305

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

B Li

P577

2017-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091427105

http://www.w3.org/2001/XMLSchema#string

P698

28869603

http://www.w3.org/2001/XMLSchema#string

P932

5730463

http://www.w3.org/2001/XMLSchema#string

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.

about

P2860

P2860

A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932